Epstein–Barr virus present in T cells or B cells shows differential effects on hemophagocytic symptoms associated with outcome in T-cell lymphomas

References

• Swerdlow SH, Campo E, Harris NL, et al. WHO classification of tumours of haematopoietic and lymphoid tissues. Lyon: IARC; 2008.
   Google Scholar
• Young LS, Rickinson AB. Epstein-Barr virus: 40 years on. Nat Rev Cancer 2004;4:757–768.
   PubMed Web of Science ®Google Scholar
• Chang KC, Huang GC, Jones D, et al. Distribution and prognosis of WHO lymphoma subtypes in Taiwan reveals a low incidence of germinal-center derived tumors. Leuk Lymphoma 2004;45:1375–1384.
   PubMed Web of Science ®Google Scholar
• Cheng AL, Su IJ, Chen YC, et al. Characteristic clinicopathologic features of Epstein-Barr virus-associated peripheral T-cell lymphoma. Cancer 1993;72:909–916.
   PubMed Web of Science ®Google Scholar
• d’Amore F, Johansen P, Houmand A, et al. Epstein-Barr virus genome in non-Hodgkin's lymphomas occurring in immunocompetent patients: highest prevalence in nonlymphoblastic T-cell lymphoma and correlation with a poor prognosis. Danish Lymphoma Study Group, LYFO. Blood 1996;87:1045–1055.
   PubMed Web of Science ®Google Scholar
• De Bruin PC, Jiwa NM, Van der Valk P, et al. Detection of Epstein-Barr virus nucleic acid sequences and protein in nodal T-cell lymphomas:relation between latent membrane protein-1 positivity and clinical course. Histopathology 1993;23:509–518.
   PubMed Web of Science ®Google Scholar
• Su IJ, Hsieh HC, Lin KH, et al. Aggressive peripheral T-cell lymphomas containing Epstein-Barr viral DNA: a clinicopathologic and molecular analysis. Blood 1991;77:799–808.
   PubMed Web of Science ®Google Scholar
• Jones JF, Shurin S, Abramowsky C, et al. T-cell lymphomas containing Epstein-Barr viral DNA in patients with chronic Epstein-Barr virus infections. N Engl J Med 1988;318:733–741.
   PubMed Web of Science ®Google Scholar
• Anagnostopoulos I, Hummel M, Finn T, et al. Heterogeneous Epstein-Barr virus infection patterns in peripheral T-cell lymphoma of angioimmunoblastic lymphadenopathy type. Blood 1992;80: 1804–1812.
   PubMed Web of Science ®Google Scholar
• Dupuis J, Emile JF, Mounier N, et al. Prognostic significance of Epstein-Barr virus in nodal peripheral T-cell lymphoma, unspecified: a Groupe d’Etude des Lymphomes de l’Adulte (GELA) study. Blood 2006;108:4163–4169.
   PubMed Web of Science ®Google Scholar
• Zettl A, Lee SS, Rudiger T, et al. Epstein-Barr virus-associated B-cell lymphoproliferative disorders in angloimmunoblastic T-cell lymphoma and peripheral T-cell lymphoma, unspecified. Am J Clin Pathol 2002;117:368–379.
   PubMed Web of Science ®Google Scholar
• Weisenburger DD, Savage KJ, Harris NL, et al. Peripheral T-cell lymphoma, not otherwise specified: a report of 340 cases from the International Peripheral T-cell Lymphoma Project. Blood 2011;117:3402–3408.
   PubMed Web of Science ®Google Scholar
• Gallamini A, Stelitano C, Calvi R, et al. Peripheral T-cell lymphoma unspecified (PTCL-U): a new prognostic model from a retrospective multicentric clinical study. Blood 2004;103:2474–2479.
   PubMed Web of Science ®Google Scholar
• Favara BE. Hemophagocytic lymphohistiocytosis: a hemophagocytic syndrome. Semin Diagn Pathol 1992;9:63–74.
   PubMed Web of Science ®Google Scholar
• Goel S, Polski JM, Imran H. Sensitivity and specificity of bone marrow hemophagocytosis in hemophagocytic lymphohistiocytosis. Ann Clin Lab Sci 2012;42:21–25.
   PubMed Web of Science ®Google Scholar
• Henter JI, Horne A, Arico M, et al. HLH-2004: diagnostic and therapeutic guidelines for hemophagocytic lymphohistiocytosis. Pediatr Blood Cancer 2007;48:124–131.
   PubMed Web of Science ®Google Scholar
• Castillo JJ, Morales D, Quinones P, et al. Lymphopenia as a prognostic factor in patients with peripheral T-cell lymphoma, unspecified. Leuk Lymphoma 2010;51:1822–1828.
   PubMed Web of Science ®Google Scholar
• Repetto L, Fratino L, Audisio RA, et al. Comprehensive geriatric assessment adds information to Eastern Cooperative Oncology Group performance status in elderly cancer patients: an Italian Group for Geriatric Oncology Study. J Clin Oncol 2002;20: 494–502.
   PubMed Web of Science ®Google Scholar
• Chen YL, Su IJ, Cheng HY, et al. BIOMED-2 protocols to detect clonal immunoglobulin and T-cell receptor gene rearrangements in B- and T-cell lymphomas in southern Taiwan. Leuk Lymphoma 2010;51:650–655.
   PubMed Web of Science ®Google Scholar
• Brauninger A, Spieker T, Willenbrock K, et al. Survival and clonal expansion of mutating “forbidden” (immunoglobulin receptor-deficient) Epstein-Barr virus-infected B cells in angioimmunoblastic T cell lymphoma. J Exp Med 2001;194:927–940.
   PubMed Web of Science ®Google Scholar
• Thorley-Lawson DA. Epstein-Barr virus: exploiting the immune system. Nat Rev Immunol 2001;1:75–82.
   PubMed Web of Science ®Google Scholar
• Song HL, Huang WY, Chen YP, et al. Tumorous proliferations of plasmacytoid dendritic cells and Langerhans cells associated with acute myeloid leukaemia. Histopathology 2012;61:974–983.
   PubMed Web of Science ®Google Scholar
• Kaplan EL, Meier P. Nonparametric estimation from incomplete observations. J Am Stat Assoc 1958;53457–53481.
   Google Scholar
• Gehan EA. A generalized two-sample Wilcoxon test for doubly censored data. Biometrika 1965;52:650–653.
   PubMed Web of Science ®Google Scholar
• Cox DR. Regression models and life tables. J R Stat Soc B 1972; B34187–B34220.
   Google Scholar
• Chien ML, Hammarskjold ML. Epstein-Barr virus latent membrane protein (LMP1) induces specific NFkappaB complexes in human T-lymphoid cells. Virus Res 2000;67:17–30.
   PubMed Web of Science ®Google Scholar
• Chuang HC, Lay JD, Hsieh WC, et al. Epstein-Barr virus LMP1 inhibits the expression of SAP gene and upregulates Th1 cytokines in the pathogenesis of hemophagocytic syndrome. Blood 2005;106: 3090–3096.
   PubMed Web of Science ®Google Scholar
• Lay JD, Tsao CJ, Chen JY, et al. Upregulation of tumor necrosis factor-alpha gene by Epstein-Barr virus and activation of macrophages in Epstein-Barr virus-infected T cells in the pathogenesis of hemophagocytic syndrome. J Clin Invest 1997;100:1969–1979.
   PubMed Web of Science ®Google Scholar
• Imadome K, Yajima M, Arai A, et al. Novel mouse xenograft models reveal a critical role of CD4 + T cells in the proliferation of EBV-infected T and NK cells. PLoS Pathog 2011;7:e1002326.
   PubMed Web of Science ®Google Scholar
• Yang L, Aozasa K, Oshimi K, et al. Epstein-Barr virus (EBV)-encoded RNA promotes growth of EBV-infected T cells through interleukin-9 induction. Cancer Res 2004;64:5332–5337.
   PubMed Web of Science ®Google Scholar
• Chuang HC, Lay JD, Chuang SE, et al. Epstein-Barr virus (EBV) latent membrane protein-1 down-regulates tumor necrosis factor-alpha (TNF-alpha) receptor-1 and confers resistance to TNF-alpha-induced apoptosis in T cells: implication for the progression to T-cell lymphoma in EBV-associated hemophagocytic syndrome. Am J Pathol 2007;170:1607–1617.
   PubMed Web of Science ®Google Scholar
• Cheung MM, Chan JK, Lau WH, et al. Primary non-Hodgkin's lymphoma of the nose and nasopharynx: clinical features, tumor immunophenotype, and treatment outcome in 113 patients. J Clin Oncol 1998;16:70–77.
   PubMed Web of Science ®Google Scholar
• Kwong YL, Chan AC, Liang R, et al. CD56 + NK lymphomas: clinicopathological features and prognosis. Br J Haematol 1997;97: 821–829.
   PubMed Web of Science ®Google Scholar
• Matsumura Y, Kuroda J, Shimura Y, et al. Cyclosporine A and reduced-intensity conditioning allogeneic stem cell transplantation for relapsed angioimmunoblastic T cell lymphoma with hemophagocytic syndrome. Intern Med 2012;51:2785–2787.
   PubMed Web of Science ®Google Scholar
• Takahashi N, Miura I, Chubachi A, et al. A clinicopathological study of 20 patients with T/natural killer (NK)-cell lymphoma-associated hemophagocytic syndrome with special reference to nasal and nasal-type NK/T-cell lymphoma. Int J Hematol 2001;74:303–308.
   PubMed Web of Science ®Google Scholar
• Takai K, Sanada M. [Angioimmunoblastic T-cell lymphoma associated with hemophagocytic syndrome at onset and relapse]. Rinsho Ketsueki 2000;41:1260–1266.
   PubMedGoogle Scholar
• Yu JT, Hwang WL, Wang RC, et al. Reduced intensity conditioning allogeneic hematopoietic stem cell transplant could be beneficial to angioimmunoblastic T-cell lymphoma patients with hemophagocytic lymphohistiocytosis. Ann Hematol 2012;91:805–807.
   PubMed Web of Science ®Google Scholar
• Tan BT, Warnke RA, Arber DA. The frequency of B- and T-cell gene rearrangements and epstein-barr virus in T-cell lymphomas: a comparison between angioimmunoblastic T-cell lymphoma and peripheral T-cell lymphoma, unspecified with and without associated B-cell proliferations. J Mol Diagn 2006;8:466–475; quiz 527.
   PubMed Web of Science ®Google Scholar
• Vergier B, Dubus P, Kutschmar A, et al. Combined analysis of T cell receptor gamma and immunoglobulin heavy chain gene rearrangements at the single-cell level in lymphomas with dual genotype. J Pathol 2002;198:171–180.
   PubMed Web of Science ®Google Scholar
• Knecht H, Martius F, Bachmann E, et al. A deletion mutant of the LMP1 oncogene of Epstein-Barr virus is associated with evolution of angioimmunoblastic lymphadenopathy into B immunoblastic lymphoma. Leukemia 1995;9:458–465.
   PubMed Web of Science ®Google Scholar
• Hochberg D, Souza T, Catalina M, et al. Acute infection with Epstein-Barr virus targets and overwhelms the peripheral memory B-cell compartment with resting, latently infected cells. J Virol 2004;78:5194–5204.
   PubMed Web of Science ®Google Scholar
• Dunleavy K, Wilson WH, Jaffe ES. Angioimmunoblastic T cell lymphoma:pathobiological insights and clinical implications. Curr Opin Hematol 2007;14:348–353.
   PubMed Web of Science ®Google Scholar
• Calattini S, Sereti I, Scheinberg P, et al. Detection of EBV genomes in plasmablasts/plasma cells and non-B cells in the blood of most patients with EBV lymphoproliferative disorders by using Immuno-FISH. Blood 2010;116:4546–4559.
   PubMed Web of Science ®Google Scholar
• Hudnall SD, Ge Y, Wei L, et al. Distribution and phenotype of Epstein-Barr virus-infected cells in human pharyngeal tonsils. Mod Pathol 2005;18:519–527.
   PubMed Web of Science ®Google Scholar
• Fischer E, Delibrias C, Kazatchkine MD. Expression of CR2 (the C3dg/EBV receptor, CD21) on normal human peripheral blood T lymphocytes. J Immunol 1991;146:865–869.
   PubMed Web of Science ®Google Scholar
• Trempat P, Tabiasco J, Andre P, et al. Evidence for early infection of nonneoplastic natural killer cells by Epstein-Barr virus. J Virol 2002;76:11139–11142.
   PubMed Web of Science ®Google Scholar
• Chen CL, Sadler RH, Walling DM, et al. Epstein-Barr virus (EBV) gene expression in EBV-positive peripheral T-cell lymphomas. J Virol 1993;67:6303–6308.
   PubMed Web of Science ®Google Scholar
• Kasahara Y, Yachie A, Takei K, et al. Differential cellular targets of Epstein-Barr virus (EBV) infection between acute EBV-associated hemophagocytic lymphohistiocytosis and chronic active EBV infection. Blood 2001;98:1882–1888.
   PubMed Web of Science ®Google Scholar
• Chuang HC, Lay JD, Hsieh WC, et al. Pathogenesis and mechanism of disease progression from hemophagocytic lymphohistiocytosis to Epstein-Barr virus-associated T-cell lymphoma: nuclear factor-kappa B pathway as a potential therapeutic target. Cancer Sci 2007; 98:1281–1287.
   PubMed Web of Science ®Google Scholar
• Kim YR, Kim JS, Kim SJ, et al. Lymphopenia is an important prognostic factor in peripheral T-cell lymphoma (NOS) treated with anthracycline-containing chemotherapy. J Hematol Oncol 2011;4:34.
   PubMed Web of Science ®Google Scholar
• Attygalle AD, Chuang SS, Diss TC, et al. Distinguishing angioimmunoblastic T-cell lymphoma from peripheral T-cell lymphoma, unspecified, using morphology, immunophenotype and molecular genetics. Histopathology 2007;50:498–508.
   PubMed Web of Science ®Google Scholar
• de Leval L, Rickman DS, Thielen C, et al. The gene expression profile of nodal peripheral T-cell lymphoma demonstrates a molecular link between angioimmunoblastic T-cell lymphoma (AITL) and follicular helper T (TFH) cells. Blood 2007;109:4952–4963.
   PubMed Web of Science ®Google Scholar
• Iqbal J, Weisenburger DD, Greiner TC, et al. Molecular signatures to improve diagnosis in peripheral T-cell lymphoma and prognostication in angioimmunoblastic T-cell lymphoma. Blood 2010;115:1026–1036.
   PubMed Web of Science ®Google Scholar
• Piccaluga PP, Agostinelli C, Califano A, et al. Gene expression analysis of peripheral T cell lymphoma, unspecified, reveals distinct profiles and new potential therapeutic targets. J Clin Invest 2007;117:823–834.
   PubMed Web of Science ®Google Scholar
• Asano N, Suzuki R, Kagami Y, et al. Clinicopathologic and prognostic significance of cytotoxic molecule expression in nodal peripheral T-cell lymphoma, unspecified. Am J Surg Pathol 2005;29:1284–1293.
   PubMed Web of Science ®Google Scholar